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Squamous cell carcinoma of the head and neck (SCCHN) is the
sixth commonest human malignancy with an estimate of nearly
900 000 new cases occurring worldwide in 1995 (Parkin et al,
1993). In this review, head and neck cancer is defined as squamous
cell carcinoma occurring in the upper aerodigestive tract, superior
to the clavicles, excluding skin cancer and nasopharyngeal carci-
noma. The incidence of head and neck cancer is increasing in
developing countries (Macfarlane et al, 1994). In England and
Wales, the overall incidence is stable at 5000 cases/year (14/105 of
the male and 5.5/105 of the female population), but within the head
and neck sites, tumours of the larynx and oral cavity are increasing.
Optimal management of SCCHN is by a multidisciplinary
approach combining surgery, radiotherapy and more recently
chemotherapy. The presenting tumour site and nodal status have
independent implications for both treatment and prognosis.
Despite therapeutic changes the overall survival rate from SCCHN
remains poor (Vokes et al, 1993). A component contributing to the
poor overall survival, particularly in patients initially presenting
with early tumours of the larynx, oral cavity and oropharynx, is the
10–30% chance of developing a second malignancy or multiple
primary tumour (MPT) of the aerodigestive tract or elsewhere
within 5 years (Day, 1992; Jovanic et al, 1994).
There are various criteria for multiple primary tumour develop-
ment. A classification described by Hong provides strict criteria to
exclude recurrence of SCCHN (Hong et al, 1990). This includes:
1. A MPT must occur more than 3 years from the original
diagnosis or be separated by greater than 2 cm of entirely
normal epithelium.
2. For a MPT of different histology these criteria do not apply.
3. If occurring in the lung, a MPT must be solitary and
histologically distinct if less than 3 years after the first tumour.
4. A MPT is not limited to the upper aerodigestive tract.
The increasing relevance of SCCHN, together with failure to
improve survival rates, emphasizes the need for better under-
standing of SCCHN epidemiology. Greater understanding of the
disease process may then allow targeted primary prevention of
SCCHN and secondary prevention for those at risk of MPT with
subsequent improvement in both quality and duration of life.
Slaughter et al (1953) proposed the concept of field canceriza-
tion, which suggests that the whole of the upper aerodigestive tract
is exposed to the damaging effects of environmental agents and
therefore is at risk of multiple tumour development. The field
cancerization hypothesis predicts that second or multiple primary
tumours occur as independent genetic events. Environmental
agents are undoubtedly very important when considering risks of
developing SCCHN. There is an abundance of information on
tobacco and alcohol. These agents increase risk in a dose-
dependent and independent manner. In non-drinkers, the effect of
smoking is to increase relative risk (RR) of developing SCCHN,
the increase varies between 2 and 20-fold. In some sites, larynx,
oral and pharyngeal cancer, the combined effect of alcohol and
tobacco can be multiplicative for cancer risk (RR: 2–140) (Maier
et al, 1992). Areca nut exposure, alone or as a component of
pan/betel quid, is associated with SCCHN. Tobacco and alcohol in
combination with areca nut increase the risk of developing
SCCHN (van Wyck et al, 1993; Patel et al, 1994). A smaller
increase in relative risk has also been demonstrated from exposure
to asbestos (RR: 1.3) (Muscat and Wynder, 1992), coal products
(Maier et al, 1991), viral infections (Larson et al, 1991; Fouret et
al, 1995) and long-term consumption of nitrosamine-containing
food (Rogers et al, 1995). Risk factors differ for different sites and,
therefore, when conducting epidemiological studies this must be
taken into account.
Despite the clearly defined evidence of the role of environ-
mental agents in the development of SCCHN there is also a
possibility that inherited susceptibility may be be important.
EVIDENCE SUGGESTING A GENETIC
COMPONENT IN SCCHN
Familial aggregates of cancer and increased cancer
risks amongst relatives
The occurrence of familial aggregations of cancer suggests exis-
tence of genetic predisposing factors. Families occur that exhibit a
high number of cases of cancer, which also tend to occur at
younger ages. A familial cluster of oral squamous cell cancer has
been reported which also demonstrated cases occurring at younger
ages (Ankathil et al, 1996). A study addressing the prevalence of
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Correspondence to: S Jefferiesoral cancer in an Israeli Jewish population found that, after
controlling for smoking and alcohol usage, an Ashkenazi group
had at least twice the risk of developing oral cancer compared with
other Jewish groups (Gorsky et al, 1994).
Increased risk of cancer is noted amongst relatives of patients
with SCCHN. Four recent epidemiological studies in SCCHN
have addressed the issue of familial factors in detail; these are
summarized in Table 1. Copper et al (1995) found that first-degree
relatives of patients with head and neck cancer had an increased
incidence of upper aerodigestive tract tumours (RR: 3.5). A higher
rate of upper aerodigestive tract cancer was observed amongst
siblings (RR: 14.6). Foulkes et al (1995) performed a study in
Southern Brazil which demonstrated that relative risk for devel-
oping SCCHN, if a first-degree relative had SCCHN, was 3.5. In
the same study, the relative risk of SCCHN if a sibling had devel-
oped the disease was 8.6. In a historical cohort study by the same
author (Foulkes et al, 1996) in Quebec, a relative risk of 3.79 was
seen for SCCHN in association with a family history of SCCHN.
All three studies have shown a similar magnitude of relative risk.
In contrast to this, a study by Goldstein et al (1994) found only a
slight increase in relative risk of SCCHN within families of oral
and pharyngeal cases.
There are a number of factors relating to these studies that need
to be considered. In each of these studies cases of cancer amongst
relatives were not confirmed. Attempts to collect information on
relatives’ alcohol consumption proved to be unreliable in all of the
studies. Analysis of the first-degree relative characteristics in the
studies that used spouse controls show that demographic factors
and smoking were well matched. Of note in the Goldstein study is
that smoking details were not collected for relatives and matching
was by racial group.
What can be concluded from these studies? The study by
Goldstein suggested that, at most, there was a weak familial link
between oral/pharyngeal cancer. In this study, black racial groups
with a brother with cancer had an increased risk of oral cancer
(odds ratio (OR): 7.4; confidence interval (CI): 1.8–31). This
effect was not seen in whites. The studies by Copper (1995) and
Foulkes et al (1996) (Quebec) found that familial factors may be
stronger for oral and pharyngeal than for laryngeal cancer. The
Brazilian study did not show any differences by tumour site for
familial risk. It therefore appears that there may be a familial
susceptibility to SCCHN, which is not entirely accounted for by a
shared environment.
Multiple primary tumours
There is evidence from other sites that genetically predisposed indi-
viduals tend to develop multiple cancers (e.g. bilateral breast cancer
is more likely to be familial) (Ottman et al, 1983). A study
comparing family history of upper aerodigestive tract tumours
amongst 100 patients with second primary tumours and 100 patients
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Table 1 Relative risk of SCCHN and RUDT in first-degree relatives of cases of SCCHN
Authors Copper et al, 1995 Foulkes et al, 1995 Goldstein et al, 1995 Foulkes et al, 1996
Location The Netherlands Brazil USA Quebec, Canada
No. of cases 105 754 1065 242
Type Consecutive Incident Incident and Incident and
prevalent prevalent
Source ENT clinic Hospital cases Cancer registry Head and neck clinic
No. of controls 105 1509 1182 156
Type Spouse Hospital Population Spouse
register
First-degree relatives:
Cases 617 – – 1429
Controls 618 – – 934
Relative details:
Cancer Not verified Not verified Not verified Not verified
Smoking Collected Collected Collected Collected
Alcohol Not collected Not collected Not collected Collected
RR of SCCHN in relatives of RR = 3.4 (0.8–13.7) RR = 3.5 (1.97–6.76) – RR = 3.79 (1.11–13.00)
SCCHN cases (95% CI)
Subgroup analysis RUDT RR = 3.5 (1.90–6.40) Sibling RR = 8.57  Pharynx RR = 1.7 Pharynx RR = 4.24
(95% CI) Sibling RR = 14 (3.10–69.10) (2.72–27.04) (1.10–2.80) (1.02–17.6)
Oral RR = 1.2 Oral RR = 3.82
(0.80–1.70) (1.08–13.50)
Larynx RR = 1.65
(0.35–7.61)
RUDT—respiratory and upper digestive tract; RR—relative risk; SCCHN—squamous cell carcinoma of the head and neck; CI—confidence interval.
Table 2 Relative risk of SCCHN and RUDT in first-degree relatives of MPT
cases
Authors Foulkes et al, 1996 Bongers et al, 1996
No. of cases of single  222 100
SCCHN
No. of cases of MPT 20 97
Hong criteria Yes Yes
Endpoints RR of SCCHN in first-degree Incidence of SCCHN
relatives and RUDT in first-degree
relatives (%)
Single SCCHN RR = 3.79 2.5%
MPT RR = 7.89 8.9%
P-value P = 0.009 P < 0.00001
RUDT—respiratory and upper digestive tract; RR—relative risk; MPT—
multiple primary tumours; SCCHN—squamous cell carcinoma in the head
and neck.with single-site SCCHN (prevalent cases at least 6 years from diag-
nosis) was performed by Bongers et al (1996) (Table 2). This
demonstrated that, if one or more relatives had an upper aerodiges-
tive tract tumour, this was a risk factor for MPT (OR: 3.8; CI:
2.0–7.6) (Bongers et al, 1996). Foulkes et al demonstrated that the
familial risk for SCCHN in relatives of cases with multiple primary
SCCHN was greater than for relatives with a single primary
SCCHN (RR: 7.89 vs. 3.53) and statistically significantly greater
than for controls. However, this was based upon only 26 cases with
MPT (Foulkesl, 1996). Taken together with the markedly increased
RR of cancer in relatives of individuals with MPT, the occurrence of
MPT increases the likelihood of an underlying genetic basis for
SCCHN, at least within the individuals with MPT.
Rare cancer syndromes
A number of rare syndromes occur that are clearly genetically
determined where there is a marked increased cancer risk amongst
gene carriers. Cancer tends to occur at younger ages and occurs in
the absence of carcinogen exposure. SCCHN is occasionally
featured in several inherited cancer syndromes, including families
with hereditary non-polyposis colo-rectal cancer, Fanconi’s
anaemia, Bloom’s syndrome, Xeroderma Pigmentosum and Li-
Fraumeni syndrome (Trizna and Schantz, 1992). P16 germline
mutations have been seen in individuals from families with
melanoma, pancreatic tumours and SCCHN (Yarbrough et al,
1996; Sun et al, 1997).
CONCLUSION AND FUTURE CLINICAL
IMPLICATIONS
The aetiology of SCCHN has been clearly defined in terms of the
environmental factors that predispose to this condition but until
recently little attention has been paid to the possible role of genetic
factors in SCCHN. Three recent case-control studies indicate that
family history of SCCHN is a significant risk factor for SCCHN
particularly if MPT has occurred; however, only very small
numbers of patients with MPT have been studied. Despite the
influence of environmental factors on the development of
SCCHN, it is now important to link epidemiological and clinical
data with molecular markers from tumour specimens in prospec-
tive clinical studies. This information may have important preven-
tative and therapeutic implications. We have commenced a
prospective collaborative study, supported by the Cancer Research
Campaign, to address exactly these issues.*
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